Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)

5.45
Delayed Data
As of Jun 18
 -0.13 / -2.33%
Today’s Change
3.12
Today|||52-Week Range
9.00
+65.15%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Zynerba Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 4.50. The median estimate represents a +46.79% increase from the last price of 5.45.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Zynerba Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$0.00
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.43%
 
 
 
 
 
 
Growthannually 49.47%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.